A detailed history of Parallel Advisors, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 97 shares of MNKD stock, worth $378. This represents 0.0% of its overall portfolio holdings.

Number of Shares
97
Previous 1,491 93.49%
Holding current value
$378
Previous $7,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025

SELL
$3.71 - $5.04 $5,171 - $7,025
-1,394 Reduced 93.49%
97 $0
Q2 2024

Aug 08, 2024

BUY
$4.05 - $5.43 $5,645 - $7,569
1,394 Added 1437.11%
1,491 $7,000
Q2 2022

Aug 01, 2022

BUY
$2.67 - $4.77 $258 - $462
97 New
97 $0

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.